National Notifiable Diseases Surveillance System, 1 April to 30 June 2017

A summary of diseases currently being reported by each jurisdiction is provided in Table 1. There were 75,935 notifications to the National Notifiable Diseases Surveillance System (NNDSS) between 1 April to 30 June 2017 (Table 2). The notification rate of diseases per 100,000 population for each state or territory is presented in Table 3.

Page last updated: 08 March 2018

Office of Health Protection, Department of Health

Table 1: Reporting of notifiable diseases by jurisdiction

Table 1: Reporting of notifiable diseases by jurisdiction
Disease Data received from:
Bloodborne diseases
Hepatitis (NEC) All jurisdictions
Hepatitis B (newly acquired) All jurisdictions
Hepatitis B (unspecified) All jurisdictions
Hepatitis C (newly acquired) All jurisdictions
Hepatitis C (unspecified) All jurisdictions
Hepatitis D All jurisdictions
Gastrointestinal diseases
Botulism All jurisdictions
Campylobacteriosis All jurisdictions except New South Wales
Cryptosporidiosis All jurisdictions
Haemolytic uraemic syndrome All jurisdictions
Hepatitis A All jurisdictions
Hepatitis E All jurisdictions
Listeriosis All jurisdictions
Paratyphoid All jurisdictions
Shiga toxin/verotoxin-producing Escherichia coli All jurisdictions
Salmonellosis All jurisdictions
Shigellosis All jurisdictions
Typhoid fever All jurisdictions
Quarantinable diseases
Avian influenza in humans All jurisdictions
Cholera All jurisdictions
Middle East respiratory syndrome coronavirus All jurisdictions
Plague All jurisdictions
Rabies All jurisdictions
Severe acute respiratory syndrome All jurisdictions
Smallpox All jurisdictions
Viral haemorrhagic fever All jurisdictions
Yellow fever All jurisdictions
Sexually transmissible infections
Chlamydial infection All jurisdictions
Donovanosis All jurisdictions
Gonococcal infection All jurisdictions
Syphilis < 2 years duration All jurisdictions
Syphilis > 2 years or unspecified duration All jurisdictions
Syphilis - congenital All jurisdictions
Vaccine preventable diseases
Diphtheria All jurisdictions
Haemophilus influenzae type b All jurisdictions
Influenza (laboratory confirmed) All jurisdictions
Measles All jurisdictions
Mumps All jurisdictions
Pertussis All jurisdictions
Pneumococcal disease – invasive All jurisdictions
Poliovirus infection All jurisdictions
Rubella All jurisdictions
Rubella - congenital All jurisdictions
Tetanus All jurisdictions
Varicella zoster (chickenpox) All jurisdictions except New South Wales
Varicella zoster (shingles) All jurisdictions except New South Wales
Varicella zoster (unspecified) All jurisdictions except New South Wales
Vectorborne diseases
Barmah Forest virus infection All jurisdictions
Chikungunya virus infection All jurisdictions except Australian Capital Territory
Dengue virus infection All jurisdictions
Flavivirus infection (unspecified) All jurisdictions
Japanese encephalitis virus infection All jurisdictions
Kunjin virus infection All jurisdictions
Malaria All jurisdictions
Murray Valley encephalitis virus infection All jurisdictions
Ross River virus infection All jurisdictions
Zoonoses
Anthrax All jurisdictions
Australian bat lyssavirus infection All jurisdictions
Brucellosis All jurisdictions
Leptospirosis All jurisdictions
Lyssavirus infection (NEC) All jurisdictions
Ornithosis All jurisdictions
Q fever All jurisdictions
Tularaemia All jurisdictions
Other bacterial infections
Legionellosis All jurisdictions
Leprosy All jurisdictions
Meningococcal infection – invasive All jurisdictions
Tuberculosis All jurisdictions
NEC Not elsewhere classified.

Table 2: Notifications of diseases received by state and territory health authorities, 1 April to 30 June 2017, by date of diagnosis*

Table 2: Notifications of diseases received by state and territory health authorities, 1 April to 30 June 2017, by date of diagnosis*
Disease ACT NSW NT QLD SA TAS VIC WA Total current quarter Total last quarter Total same period previous year Last 5 years mean current quarter Ratio Year to date Last 5 years YTD mean
Bloodborne diseases
Hepatitis B (newly acquired) † 0 1 3 12 4 2 9 6 37 39 43 41.2 0.9 76 88.8
Hepatitis B (unspecified) ‡ 29 614 23 202 63 11 449 127 1,518 1,544 1,860 1,638 0.9 3,060 3,207.2
Hepatitis C (newly acquired) † 3 10 4 79 7 7 17 23 150 158 184 154.2 1 307 316.2
Hepatitis C (unspecified) ‡ 37 996 39 492 91 48 494 275 2,472 2,638 2,945 2,486.2 1 5,096 4,968
Hepatitis D 0 3 0 2 0 0 3 0 8 14 15 13.8 0.6 22 27
Gastrointestinal diseases
Botulism 0 0 0 0 0 0 0 0 0 0 0 0.6 0 0 1.2
Campylobacteriosis 90 NN 123 1,649 632 135 1,413 705 4,747 6,585 5,225 4,270 1.1 11,283 9,178
Cryptosporidiosis 26 266 34 328 128 11 397 89 1,279 2,282 1,499 1,035.6 1.2 3,553 2,605.8
Haemolytic uraemic syndrome (HUS) 0 1 0 1 0 0 0 1 3 7 1 3.6 0.8 10 9.2
Hepatitis A 0 5 0 2 4 0 7 2 20 51 26 35 0.6 71 103.2
Hepatitis E 0 6 0 2 0 0 2 2 12 18 5 9.8 1.2 30 22.4
Listeriosis 0 7 0 8 1 0 2 2 20 22 23 19.8 1 42 43.8
Paratyphoid 0 0 0 1 1 0 4 1 7 27 13 16.4 0.4 34 46.2
STEC § 0 16 1 6 52 0 2 7 84 153 57 35.2 2.4 233 73.8
Salmonellosis 68 830 171 1,043 335 47 734 622 3,850 6,324 4,505 3,631.2 1.1 10,145 8,857
Shigellosis 1 47 146 70 5 3 96 36 404 403 351 207.8 1.9 807 471.2
Typhoid Fever 0 12 0 3 1 0 6 5 27 58 21 24 1.1 85 73.8
Quarantinable diseases
Avian influenza in humans (AIH) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cholera 0 0 0 0 0 0 0 0 0 0 0 1.4 0 0 1.6
Middle East respiratory syndrome coronavirus (MERS-CoV) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Plague 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Rabies 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Severe acute respiratory syndrome (SARS) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Smallpox 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Viral haemorrhagic fever (NEC) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Yellow fever 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sexually transmissible infections
Chlamydial infection ||, 390 6,910 645 5,941 1,527 414 6,428 2,800 25,055 27,493 24,904 22,037.4 1.1 52,486 44,781
Donovanosis 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2
Gonococcal infection 52 2,153 429 1,294 340 24 1,839 833 6,964 8,089 5,961 4,379.6 1.6 15,023 8,780.6
Syphilis < 2 years 4 265 84 294 42 2 321 60 1,072 1,093 875 565.6 1.9 2,163 1,105.4
Syphilis > 2 years or unspecified duration ‡, 4 133 46 73 13 4 186 36 495 537 504 450.8 1.1 1,032 890.8
Syphilis congenital 0 0 0 1 0 0 1 0 2 2 0 0.6 3.3 4 0.8
Vaccine preventable diseases
Diphtheria 0 0 0 2 0 0 1 0 3 1 3 0.6 5 4 1.2
Haemophilus influenzae type b 0 2 0 0 0 0 1 0 3 3 5 4.8 0.6 6 7.8
Influenza (laboratory confirmed) 95 4,811 83 3,295 1,928 130 2,150 521 13,013 8,339 7,326 6,297.8 2.1 21,302 9,852.4
Measles 0 5 0 1 0 0 4 1 11 41 19 31.4 0.4 52 83
Mumps 0 33 38 90 19 0 8 3 191 179 194 92.2 2.1 368 206
Pertussis 61 1,334 24 262 411 7 415 299 2,813 3,455 3,869 3,622.2 0.8 6,240 8,255.2
Pneumococcal disease (invasive) 7 165 15 71 59 7 124 50 498 254 436 437.4 1.1 752 646.6
Poliovirus infection 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Rotavirus 0 197 260 581 177 10 0 237 1,462 682 525 540.6 2.7 2,136 1,210.8
Rubella 0 2 0 0 0 0 0 0 2 5 9 6.2 0.3 7 11.8
Rubella congenital 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0.2
Tetanus 0 0 0 0 2 0 0 0 2 1 1 0.6 3.3 3 2.2
Varicella zoster (chickenpox) 19 NN 16 73 116 18 303 120 665 725 606 510.8 1.3 1,384 993.8
Varicella zoster (shingles) 64 NN 101 14 686 83 722 448 2,118 2,209 1,722 1,416 1.5 4,314 2,836.2
Varicella zoster (unspecified) 52 NN 0 1,877 25 39 1,534 389 3,916 4,124 3,838 2,948 1.3 8,016 5,918.6
Vectorborne diseases
Barmah Forest virus infection 0 55 7 74 0 0 2 11 149 111 89 478.6 0.3 260 999
Chikungunya virus infection 0 10 0 0 0 2 6 3 21 21 15 23.4 0.9 42 49.6
Dengue virus infection 6 62 12 54 5 1 50 45 235 422 710 515.6 0.5 656 1,180.2
Flavivirus infection (unspecified) 0 2 0 4 0 0 0 0 6 8 19 7 0.9 14 21.6
Japanese encephalitis virus infection 0 0 0 0 0 0 1 0 1 0 0 0.4 2.5 1 1
Malaria 6 19 3 19 2 0 7 17 73 122 74 73.2 1 195 161.8
Murray Valley encephalitis virus infection 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0.6
Ross River virus infection 2 404 35 861 65 18 134 332 1,851 3,941 1,038 1,371 1.4 5,773 3,806.4
West Nile/Kunjin virus infection 0 0 0 0 0 0 0 4 4 0 0 0.2 20 4 0.2
Zoonoses
Anthrax 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Australian bat lyssavirus infection 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2
Brucellosis 0 3 0 3 0 0 0 0 6 1 4 4 1.5 7 8.8
Leptospirosis 0 5 2 23 1 0 0 1 32 60 36 30.8 1 92 62.6
Lyssavirus infection (NEC) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Ornithosis 0 0 0 0 0 0 5 0 5 6 2 8.2 0.6 10 15
Q fever 0 53 0 53 5 1 6 2 120 135 124 121.8 1 254 252.6
Tularaemia 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other bacterial infections
Legionellosis 0 39 0 25 9 2 34 10 119 87 102 103.4 1.2 202 194.8
Leprosy 0 1 0 0 0 0 0 0 1 2 4 3.6 0.3 3 5.8
Meningococcal disease (invasive)** 0 16 0 13 9 3 18 6 65 74 46 45.6 1.4 138 79.4
Tuberculosis 7 127 3 47 15 4 102 19 324 326 296 292 1.1 649 604.4
  1,023 19,620 2,347 18,945 6,780 1,033 18,037 8,150 75,935 82,871 70,129     158,446  

*The date of diagnosis is the onset date or where the date of onset was not known, the earliest of the specimen collection date, the notification date, or the notification receive date. For hepatitis B (unspecified), hepatitis C (unspecified), leprosy, syphilis (> 2 years or unspecified duration) and tuberculosis, the public health unit notification receive date was used.
†Newly acquired hepatitis includes cases where the infection was determined to be acquired within 24 months prior to diagnosis. Queensland began reporting hepatitis C newly acquired from 1 September 2016. Previous notifications are reported under hepatitis unspecified.
‡Unspecified hepatitis and syphilis includes cases where the duration of infection could not be determined or is greater than 24 months.
§ Infection with Shiga toxin/verotoxin-producing Escherichia coli.
|| Includes Chlamydia trachomatis identified from cervical, rectal, urine, urethral and throat samples, except for South Australia, which reports only cervical, urine and urethral specimens.
The national case definitions for chlamydia, gonococcal and syphilis diagnoses include infections that may be acquired through a non-sexual mode (especially in children – e.g. perinatal infections, epidemic gonococcal conjunctivitis).
**Only invasive meningococcal disease is nationally notifiable. However, New South Wales and the Australian Capital Territory also report conjunctival cases.
NN Not notifiable
NEC Not elsewhere classified
Totals comprise data from all states and territories. Cumulative figures are subject to retrospective revision so there may be discrepancies between the number of new notifications and the increment in the cumulative figure from the previous period.

Table 3: Notification rates of diseases, 1 April to 30 June 2017, by state or territory. (Annualised rate per 100,000 population)*,†

Table 3: Notification rates of diseases, 1 April to 30 June 2017, by state or territory. (Annualised rate per 100,000 population) *,†
1 Disease ACT NSW NT QLD SA TAS VIC WA Australia
Bloodborne diseases
Hepatitis B (newly acquired) ‡ 0.0 0.1 4.9 1.0 0.9 1.5 0.6 0.9 0.6
Hepatitis B (unspecified) § 28.8 31.7 37.4 16.7 14.7 8.5 29.1 19.9 25.1
Hepatitis C (newly acquired) ‡ 3.0 0.5 6.5 6.5 1.6 5.4 1.1 3.6 2.5
Hepatitis C (unspecified) § 36.7 51.5 63.5 40.6 21.2 37.1 32.0 43.0 40.8
Hepatitis D 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.1
Gastrointestinal diseases
Botulism 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Campylobacteriosis 89.2 NN 200.2 136.0 147.6 104.3 91.5 110.2 115.3
Cryptosporidiosis 25.8 13.7 55.3 27.1 29.9 8.5 25.7 13.9 21.1
Haemolytic uraemic syndrome (HUS) 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0
Hepatitis A 0.0 0.3 0.0 0.2 0.9 0.0 0.5 0.3 0.3
Hepatitis E 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.3 0.2
Listeriosis 0.0 0.4 0.0 0.7 0.2 0.0 0.1 0.3 0.3
Paratyphoid 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.2 0.1
STEC || 0.0 0.8 1.6 0.5 12.1 0.0 0.1 1.1 1.4
Salmonellosis 67.4 42.9 278.3 86.0 78.2 36.3 47.5 97.2 63.6
Shigellosis 1.0 2.4 237.6 5.8 1.2 2.3 6.2 5.6 6.7
Typhoid Fever 0.0 0.6 0.0 0.2 0.2 0.0 0.4 0.8 0.4
Quarantinable diseases
Avian influenza in humans (AIH) 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Cholera 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Middle East respiratory syndrome coronavirus (MERS-CoV) 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Plague 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Rabies 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Severe acute respiratory syndrome (SARS) 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Smallpox 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Viral haemorrhagic fever (NEC) 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Yellow fever 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Sexually transmissible infections
Chlamydial infection ¶** 386.6 357.1 1,049.9 490.1 356.6 319.9 416.1 437.7 413.9
Donovanosis 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Gonococcal infection** 51.6 111.3 698.3 106.7 79.4 18.5 119.0 130.2 115.1
Syphilis < 2 years ** 4.0 13.7 136.7 24.3 9.8 1.5 20.8 9.4 17.7
Syphilis > 2 years or unspecified duration §** 4.0 6.9 74.9 6.0 3.0 3.1 12.0 5.6 8.2
Syphilis congenital 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0
2 Vaccine preventable diseases
Diphtheria 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0
Haemophilus influenzae type b 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0
Influenza (laboratory confirmed) 94.2 248.7 135.1 271.8 450.2 100.5 139.2 81.4 215.0
Measles 0.0 0.3 0.0 0.1 0.0 0.0 0.3 0.2 0.2
Mumps 0.0 1.7 61.9 7.4 4.4 0.0 0.5 0.5 3.2
Pertussis 60.5 68.9 39.1 21.6 96.0 5.4 26.9 46.7 46.5
Pneumococcal disease (invasive) 6.9 8.5 24.4 5.9 13.8 5.4 8.0 7.8 8.2
Poliovirus infection 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Rotavirus 0.0 10.2 423.2 47.9 41.3 7.7 0.0 37.0 24.2
Rubella 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Rubella congenital 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Tetanus 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0
Varicella zoster (chickenpox) 18.8 NN 26.0 6.0 27.1 13.9 19.6 18.8 16.1
Varicella zoster (shingles) 63.4 NN 164.4 1.2 160.2 64.1 46.7 70.0 51.4
Varicella zoster (unspecified) 51.6 NN 0.0 154.8 5.8 30.1 99.3 60.8 95.1
Vectorborne diseases
Barmah Forest virus infection 0.0 2.8 11.4 6.1 0.0 0.0 0.1 1.7 2.5
Chikungunya virus infection 0.0 0.5 0.0 0.0 0.0 1.5 0.4 0.5 0.3
Dengue virus infection 5.9 3.2 19.5 4.5 1.2 0.8 3.2 7.0 3.9
Flavivirus infection (unspecified) 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1
Japanese encephalitis virus infection 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0
Malaria 5.9 1.0 4.9 1.6 0.5 0.0 0.5 2.7 1.2
Murray Valley encephalitis virus infection 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Ross River virus infection 2.0 20.9 57.0 71.0 15.2 13.9 8.7 51.9 30.6
West Nile/Kunjin virus infection 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1
Zoonoses
Anthrax 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Australian bat lyssavirus infection 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Brucellosis 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1
Leptospirosis 0.0 0.3 3.3 1.9 0.2 0.0 0.0 0.2 0.5
Lyssavirus infection (NEC) 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Ornithosis 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1
Q fever 0.0 2.7 0.0 4.4 1.2 0.8 0.4 0.3 2.0
Tularaemia 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Other bacterial infections
Legionellosis 0.0 2.0 0.0 2.1 2.1 1.5 2.2 1.6 2.0
Leprosy 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Meningococcal disease (invasive) †† 0.0 0.8 0.0 1.1 2.1 2.3 1.2 0.9 1.1
Tuberculosis 6.9 6.6 4.9 3.9 3.5 3.1 6.6 3.0 5.4
*The date of diagnosis is the onset date or where the date of onset was not known, the earliest of the specimen collection date, the notification date, or the notification receive date. For hepatitis B (unspecified), hepatitis C (unspecified), leprosy, syphilis (> 2 years or unspecified duration) and tuberculosis, the public health unit notification receive date was used.
†Rate per 100,000 of population. Annualisation Factor was 4.0
‡Newly acquired hepatitis includes cases where the infection was determined to be acquired within 24 months prior to diagnosis. Queensland began reporting hepatitis C newly acquired from 1 September 2016. Previous notifications are reported under hepatitis unspecified.
§Unspecified hepatitis and syphilis includes cases where the duration of infection could not be determined or is greater than 24 months.
|| Infection with Shiga toxin/verotoxin-producing Escherichia coli.
Includes Chlamydia trachomatis identified from cervical, rectal, urine, urethral and throat samples, except for South Australia, which reports only cervical, urine and urethral specimens.
** The national case definitions for chlamydia, gonococcal and syphilis diagnoses include infections that may be acquired through a non-sexual mode (especially in children – e.g. perinatal infections, epidemic gonococcal conjunctivitis).
††Only invasive meningococcal disease is nationally notifiable. However, New South Wales and the Australian Capital Territory also report conjunctival cases.
NEC Not elsewhere classified.
NN Not notifiable.

In this section